FDA APPROVES FLUVOXAMINE EXTENDED RELEASE FOR TREATMENT OF SAD AND OCD IN ADULTS.
- Published in:
- Primary Psychiatry, 2008, v. 15, n. 4, p. 16
- By:
- Publication type:
- Article
Works matching DE "JAZZ Pharmaceuticals Inc."
Results: 7
1
2
Market watch: Upcoming market catalysts in Q4 2010.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 10, p. 755, doi. 10.1038/nrd3286
- By:
- Publication type:
- Article
3
CLINICAL TRIALS NEWS.
- Published in:
- Applied Clinical Trials, 2006, v. 15, n. 10, p. 18
- Publication type:
- Article
4
Jazz beefs up with EUSA biologic.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 7, p. 574, doi. 10.1038/nbt0712-574a
- By:
- Publication type:
- Article
5
Acquisitions underway.
- Published in:
- Chemistry & Industry, 2005, n. 9, p. 4
- By:
- Publication type:
- Article
6
From the FDA.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2008, v. 10, n. 4, p. 8
- Publication type:
- Article
7
NEWS IN BRIEF.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 5, p. 497, doi. 10.1038/nbt0504-497
- By:
- Publication type:
- Article